|
ESLAW Estrella Immunopharma 1844417 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,292,064.00 |
| Balance Sheet |
|
Current Assets
|
$2,157,198.00 |
|
Assets
|
$3,657,198.00 |
|
Current Liabilities
|
$8,927,494.00 |
|
Liabilities
|
$8,927,494.00 |
|
Equity
|
$-5,270,296.00 |
|
Shares Out
|
37765589.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,698,010.00 |
|
Investing Cash Flow
|
$4,960,647.00 |
| Market Analysis |
Market Cap
|
$2,265,935.34 |
|
Price
|
$0.10 |
|
EPS
|
-0.05 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:59 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:04 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ESLAW documents filed with the SEC.
ESLAW Filings
Clear
